Argan financials
$378.39+6.53%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '27 Jul 31 | Q1 '27 Apr 30 | Q4 '26 Jan 31 | Q3 '26 Oct 31 | Q2 '26 Jul 31 | Q1 '26 Apr 30 | Q4 '25 Jan 31 | Q3 '25 Oct 31 | Q2 '25 Jul 31 | Q1 '25 Apr 30 | Q4 '24 Jan 31 | Q3 '24 Oct 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $384.0M | $291.0M | $262.1M | $251.2M | $237.7M | $193.7M | $232.5M | $257.0M | $227.0M | $157.7M | $164.6M | $163.8M |
| Gross profit | $74.2M | $61.1M | $65.6M | $46.9M | $44.3M | $36.9M | $47.6M | $44.3M | $31.1M | $17.9M | $23.6M | $19.2M |
| Gross margin | 19.3% | 21.0% | 25.0% | 18.7% | 18.6% | 19.0% | 20.5% | 17.2% | 13.7% | 11.4% | 14.4% | 11.7% |
| Operating income | $56.8M | $45.4M | $47.7M | $32.6M | $30.1M | $24.3M | $32.7M | $30.3M | $18.7M | $6.5M | $11.7M | $7.9M |
| Net income | $53.3M | $46.1M | $49.2M | $30.7M | $35.3M | $22.6M | $31.4M | $28.0M | $18.2M | $7.9M | $12.0M | $5.5M |
| Net margin | 13.9% | 15.8% | 18.8% | 12.2% | 14.8% | 11.6% | 13.5% | 10.9% | 8.0% | 5.0% | 7.3% | 3.3% |
| Diluted EPS | $3.76 | $3.24 | $3.47 | $2.17 | $2.50 | $1.60 | $2.22 | $2.00 | $1.31 | $0.58 | $0.89 | $0.40 |
| EBITDA | $57.5M | $46.0M | $48.2M | $33.1M | $30.5M | $24.8M | $33.2M | $30.8M | $19.1M | $7.0M | $11.9M | $8.4M |
| Operating cash flow | $97.0M | $113.4M | $172.3M | $172.5M | $34.6M | $35.3M | $44.6M | $31.8M | $73.5M | $17.7M | $24.6M | $57.7M |
| Free cash flow | $91.7M | $111.0M | $171.1M | $171.9M | $32.9M | $34.9M | $43.3M | $29.2M | $71.1M | $17.4M | $24.0M | $56.6M |
| Diluted shares | 14.2M | 14.2M | 14.2M | 14.2M | 14.1M | 14.1M | 14.1M | 14.0M | 13.9M | 13.6M | 13.5M | 13.6M |
Balance sheet
| Period end | Jul 31 | Apr 30 | Jan 31 | Oct 31 | Jul 31 | Apr 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $364.5M | $355.8M | $339.5M | $306.3M | $177.8M | $189.3M |
| Short-term investments | $664.0M | $617.7M | $555.5M | $420.5M | $394.3M | $357.2M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $1.40B | $1.29B | $1.19B | $1.05B | $882.7M | $792.2M |
| Total liabilities | $894.1M | $812.9M | $724.1M | $631.2M | $489.5M | $428.3M |
| Shareholders' equity | $506.8M | $473.5M | $462.3M | $419.7M | $393.2M | $363.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology